Guardion Health Sciences, Inc. (GHSI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
2925 RICHMOND AVENUE HOUSTON, TX 77098 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 10,655 | 9,090 | 8,519 | 11,116 | 671 | 4,735 | |||
| Cash and cash equivalents | 10,655 | 4,094 | 8,519 | 11,116 | 671 | 4,735 | |||
| Short-term investments | 4,996 | ||||||||
| Receivables | 1,924 | 1,412 | 11 | 78 | 28 | 73 | |||
| Inventory, net of allowances, customer advances and progress billings | 3,119 | 368 | 385 | 311 | 358 | 155 | |||
| Inventory | 3,119 | 368 | 385 | 311 | 358 | 155 | |||
| Prepaid expense | 180 | 363 | 48 | ||||||
| Other current assets | 441 | 76 | |||||||
| Other undisclosed current assets | 5,938 | 1,200 | (441) | (76) | 117 | ||||
| Total current assets: | 21,637 | 12,069 | 9,095 | 11,868 | 1,105 | 5,080 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 24 | 419 | 573 | ✕ | ✕ | ||||
| Property, plant and equipment | 49 | 111 | 286 | 375 | 275 | 96 | |||
| Intangible assets, net (including goodwill) | 11,256 | 50 | 50 | 2,020 | 2,184 | ||||
| Goodwill | 1,564 | 1,564 | |||||||
| Intangible assets, net (excluding goodwill) | 11,256 | 50 | 50 | 456 | 621 | ||||
| Deposits noncurrent assets | 12 | 12 | |||||||
| Deferred costs | 270 | ||||||||
| Other noncurrent assets | 12 | 12 | 12 | ||||||
| Other undisclosed noncurrent assets | (12) | (12) | 10 | ||||||
| Total noncurrent assets: | 49 | 11,391 | 766 | 1,009 | 2,576 | 2,290 | |||
| TOTAL ASSETS: | 21,686 | 23,461 | 9,861 | 12,877 | 3,681 | 7,370 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 2,076 | 1,137 | 736 | 129 | 414 | 311 | |||
| Accounts payable | 1,518 | 241 | 608 | ||||||
| Accrued liabilities | 558 | 895 | 128 | ||||||
| Other undisclosed accounts payable and accrued liabilities | 129 | 414 | 311 | ||||||
| Debt | 152 | 31 | |||||||
| Deferred rent credit | 116 | 81 | ✕ | ||||||
| Derivative instruments and hedges, liabilities | 26 | 13 | |||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 12 | ||
| Due to related parties | ✕ | 298 | 146 | ||||||
| Other undisclosed current liabilities | 1,935 | 22 | 14 | ||||||
| Total current liabilities: | 4,012 | 1,159 | 1,074 | 410 | 495 | 500 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 4 | 272 | 435 | ||||||
| Operating lease, liability | 4 | 272 | 435 | ✕ | ✕ | ||||
| Other undisclosed noncurrent liabilities | 4,507 | (4) | (272) | ||||||
| Total noncurrent liabilities: | 4,507 | 4 | 272 | 435 | |||||
| Total liabilities: | 8,518 | 1,163 | 1,346 | 845 | 495 | 500 | |||
| Temporary equity, carrying amount | 5,250 | ||||||||
| Equity | |||||||||
| Equity, attributable to parent | 7,918 | 22,298 | 8,515 | 12,032 | 3,186 | 6,870 | |||
| Common stock | 1 | 24 | 15 | 75 | 21 | 40 | |||
| Additional paid in capital | 101,641 | 101,075 | 62,583 | 57,469 | 37,799 | 33,696 | |||
| Accumulated deficit | (93,724) | (78,802) | (54,083) | (45,512) | (34,633) | (26,866) | |||
| Total equity: | 7,918 | 22,298 | 8,515 | 12,032 | 3,186 | 6,870 | |||
| TOTAL LIABILITIES AND EQUITY: | 21,686 | 23,461 | 9,861 | 12,877 | 3,681 | 7,370 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 11,050 | 7,233 | 1,890 | 903 | 942 | 437 | ||
| Amortization of lease incentives | ✕ | ✕ | ✕ | (148) | ✕ | |||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 437 | |
| Cost of revenue (Cost of Goods and Services Sold) | (6,529) | (4,123) | (1,947) | (341) | (398) | (175) | ||
| Gross profit: | 4,520 | 3,110 | (57) | 562 | 544 | 262 | ||
| Operating expenses | (21,941) | (27,857) | (8,495) | (11,059) | (6,688) | (5,543) | ||
| Operating loss: | (17,421) | (24,747) | (8,552) | (10,497) | (6,144) | (5,281) | ||
| Nonoperating income (expense) | 2,498 | 2 | (20) | 381 | (1,624) | |||
| Interest and debt expense | (7) | (258) | (2) | (24) | ||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | ||||||||
| Loss from continuing operations: | (14,922) | (24,745) | (8,579) | (10,374) | (7,770) | (5,305) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (24,745) | (8,579) | (10,374) | (7,770) | (5,305) | |
| Net loss: | (14,922) | (24,745) | (8,579) | (10,374) | (7,770) | (5,305) | ||
| Other undisclosed net income (loss) attributable to parent | 7 | (504) | 2 | |||||
| Net loss attributable to parent: | (14,922) | (24,745) | (8,572) | (10,878) | (7,767) | (5,305) | ||
| Preferred stock dividends and other adjustments | (309) | |||||||
| Other undisclosed net loss available to common stockholders, basic | (942) | (602) | ||||||
| Net loss available to common stockholders, diluted: | (15,864) | (24,745) | (8,572) | (10,878) | (7,767) | (6,216) | ||
Comprehensive Income ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (14,922) | (24,745) | (8,579) | (10,374) | (7,770) | (5,305) | ||
| Comprehensive loss, net of tax, attributable to parent: | (14,922) | (24,745) | (8,579) | (10,374) | (7,770) | (5,305) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.